Glaucoma Surgical Device Market to Grow More than 28 Percent by 2022

October 4, 2017: By Market Scope

Market Scope forecasts that the glaucoma surgical device market will grow at a compound annual growth rate (CAGR) of 28.2 percent a year, totaling $1.8 billion by 2022.

Glaucoma is the world’s second leading cause of blindness, and the disease affects more than 80 million people around the globe, according to Market Scope estimates. Diagnosis and treatment are widely available in wealthy nations, but this is not the case in many underdeveloped countries. We estimate that only 32.5 million, or 35.9 percent of individuals with glaucoma, are diagnosed. Of those, only about 713 thousand, or 22 percent, will have surgery. However, newer glaucoma surgical technologies—advanced technology glaucoma surgery (ATGS) drainage devices—offer the promise of safer and more effective outcomes and are already leading to earlier surgical intervention in the treatment paradigm.

ATGS drainage device revenues account for just over half of total market revenues. The largest ATGS category, minimally-invasive glaucoma surgery (MIGS) drainage implants, will account for most of the growth over the next five years, but product improvements are also expected in diagnostic devices, pharmaceuticals, lasers, and other surgical devices. MIGS stents are expected to grow at a CAGR of nearly 44 percent, to $1.36 billion by 2022.

Eleven manufacturers of glaucoma surgical products account for roughly 79 percent of all market revenues. The largest of these are Glaukos, Alcon, and New World Medical.

Market Scope published its 2017 Glaucoma Surgical Device Report: A Global Market Analysis for 2016 to 2022 in August 2017. It is the only source for accurate and relevant information on all aspects of the glaucoma surgical device market. In this report, Market Scope divides the glaucoma surgical device market into four broad categories: conventional glaucoma surgery (CGS) devices, ATGS devices, selective laser trabeculoplasty (SLT) lasers, and disposables/instruments. The report includes market data for 2016, and we forecast market performance through 2022. We cover prevalence and forecasts for glaucoma worldwide, and we discuss the ophthalmologists who treat the disease. We examine the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. We forecast product demand in units and dollars, and we analyze market shares by product category. Our forecast also subdivides the market into eight geographic/economic analytic categories: the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World.

Coming soon

2017 Dry Eye Products Report: A Global Market Analysis for 2016 to 2022